US Stock MarketDetailed Quotes

MNPR Monopar Therapeutics

Watchlist
  • 5.2600
  • +0.1100+2.14%
Close Oct 16 16:00 ET
  • 5.1565
  • -0.1035-1.97%
Post 20:02 ET
18.52MMarket Cap-2286P/E (TTM)

Monopar Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-30.15%7.12M
-24.69%8.79M
-44.62%7.27M
-44.62%7.27M
-40.66%8.49M
-38.10%10.19M
-34.47%11.68M
-35.38%13.12M
-35.38%13.12M
-35.92%14.32M
-Cash and cash equivalents
-15.17%6.12M
36.36%7.81M
-11.24%7.27M
-11.24%7.27M
-61.48%5.52M
-56.18%7.21M
-67.87%5.73M
-59.68%8.19M
-59.68%8.19M
-35.92%14.32M
-Short-term investments
-66.44%998.84K
-83.43%985.73K
--0
--0
--2.98M
--2.98M
--5.95M
--4.93M
--4.93M
----
Other current assets
-44.46%61.02K
11.39%118.99K
44.48%66.43K
44.48%66.43K
31.41%73.19K
-41.92%109.87K
-44.83%106.82K
-78.88%45.98K
-78.88%45.98K
-47.85%55.7K
Total current assets
-30.30%7.18M
-24.36%8.91M
-44.31%7.33M
-44.31%7.33M
-40.38%8.57M
-38.14%10.3M
-34.58%11.78M
-35.84%13.17M
-35.84%13.17M
-35.98%14.37M
Non current assets
Net PPE
--0
--0
-79.35%12.65K
-79.35%12.65K
-65.58%25.09K
-55.75%37.33K
-8.04%49.38K
--61.23K
--61.23K
--72.89K
-Gross PPE
--0
--0
-79.35%12.65K
-79.35%12.65K
-65.58%25.09K
-55.75%37.33K
-8.04%49.38K
--61.23K
--61.23K
--72.89K
Total non current assets
--0
--0
-79.35%12.65K
-79.35%12.65K
-65.58%25.09K
-55.75%37.33K
-8.04%49.38K
--61.23K
--61.23K
5.85%72.89K
Total assets
-30.55%7.18M
-24.68%8.91M
-44.47%7.35M
-44.47%7.35M
-40.51%8.59M
-38.23%10.34M
-34.51%11.83M
-35.55%13.23M
-35.55%13.23M
-35.85%14.45M
Liabilities
Current liabilities
Current liabilities
-56.45%1.09M
-50.30%1.44M
-43.83%1.76M
-43.83%1.76M
3.53%1.98M
14.40%2.5M
168.85%2.89M
97.96%3.13M
97.96%3.13M
54.39%1.91M
Non current liabilities
Long term debt and capital lease obligation
----
----
--0
--0
--0
--0
--0
--8.41K
--8.41K
--20.85K
-Long term capital lease obligation
----
----
--0
--0
--0
--0
--0
--8.41K
--8.41K
--20.85K
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--8.41K
--8.41K
--20.85K
Total liabilities
-56.45%1.09M
-50.30%1.44M
-43.98%1.76M
-43.98%1.76M
2.41%1.98M
12.69%2.5M
162.65%2.89M
98.50%3.14M
98.50%3.14M
56.07%1.94M
Shareholders'equity
Share capital
26.65%17.6K
32.23%17.48K
15.12%14.91K
15.12%14.91K
10.44%14.2K
9.42%13.9K
4.76%13.22K
2.77%12.95K
2.77%12.95K
2.10%12.86K
-common stock
26.65%17.6K
32.23%17.48K
15.12%14.91K
15.12%14.91K
10.44%14.2K
9.42%13.9K
4.76%13.22K
2.77%12.95K
2.77%12.95K
2.10%12.86K
Retained earnings
-12.62%-63.56M
-14.03%-61.85M
-16.22%-60.21M
-16.22%-60.21M
-19.39%-58.39M
-21.35%-56.44M
-23.99%-54.24M
-25.47%-51.8M
-25.47%-51.8M
-26.68%-48.91M
Paid-in capital
8.36%69.63M
9.76%69.3M
6.34%65.79M
6.34%65.79M
5.91%64.99M
5.34%64.25M
4.01%63.14M
2.74%61.87M
2.74%61.87M
2.48%61.36M
Gains losses not affecting retained earnings
14.35%8.26K
-86.69%4.23K
-258.04%-14.13K
-258.04%-14.13K
-90.81%3.95K
-58.65%7.22K
949.01%31.79K
382.97%8.94K
382.97%8.94K
935.15%42.99K
Total stockholders'equity
-22.29%6.09M
-16.41%7.48M
-44.62%5.59M
-44.62%5.59M
-47.15%6.61M
-46.02%7.84M
-47.28%8.94M
-46.73%10.09M
-46.73%10.09M
-41.21%12.51M
Total equity
-22.29%6.09M
-16.41%7.48M
-44.62%5.59M
-44.62%5.59M
-47.15%6.61M
-46.02%7.84M
-47.28%8.94M
-46.73%10.09M
-46.73%10.09M
-41.21%12.51M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -30.15%7.12M-24.69%8.79M-44.62%7.27M-44.62%7.27M-40.66%8.49M-38.10%10.19M-34.47%11.68M-35.38%13.12M-35.38%13.12M-35.92%14.32M
-Cash and cash equivalents -15.17%6.12M36.36%7.81M-11.24%7.27M-11.24%7.27M-61.48%5.52M-56.18%7.21M-67.87%5.73M-59.68%8.19M-59.68%8.19M-35.92%14.32M
-Short-term investments -66.44%998.84K-83.43%985.73K--0--0--2.98M--2.98M--5.95M--4.93M--4.93M----
Other current assets -44.46%61.02K11.39%118.99K44.48%66.43K44.48%66.43K31.41%73.19K-41.92%109.87K-44.83%106.82K-78.88%45.98K-78.88%45.98K-47.85%55.7K
Total current assets -30.30%7.18M-24.36%8.91M-44.31%7.33M-44.31%7.33M-40.38%8.57M-38.14%10.3M-34.58%11.78M-35.84%13.17M-35.84%13.17M-35.98%14.37M
Non current assets
Net PPE --0--0-79.35%12.65K-79.35%12.65K-65.58%25.09K-55.75%37.33K-8.04%49.38K--61.23K--61.23K--72.89K
-Gross PPE --0--0-79.35%12.65K-79.35%12.65K-65.58%25.09K-55.75%37.33K-8.04%49.38K--61.23K--61.23K--72.89K
Total non current assets --0--0-79.35%12.65K-79.35%12.65K-65.58%25.09K-55.75%37.33K-8.04%49.38K--61.23K--61.23K5.85%72.89K
Total assets -30.55%7.18M-24.68%8.91M-44.47%7.35M-44.47%7.35M-40.51%8.59M-38.23%10.34M-34.51%11.83M-35.55%13.23M-35.55%13.23M-35.85%14.45M
Liabilities
Current liabilities
Current liabilities -56.45%1.09M-50.30%1.44M-43.83%1.76M-43.83%1.76M3.53%1.98M14.40%2.5M168.85%2.89M97.96%3.13M97.96%3.13M54.39%1.91M
Non current liabilities
Long term debt and capital lease obligation ----------0--0--0--0--0--8.41K--8.41K--20.85K
-Long term capital lease obligation ----------0--0--0--0--0--8.41K--8.41K--20.85K
Total non current liabilities --0--0--0--0--0--0--0--8.41K--8.41K--20.85K
Total liabilities -56.45%1.09M-50.30%1.44M-43.98%1.76M-43.98%1.76M2.41%1.98M12.69%2.5M162.65%2.89M98.50%3.14M98.50%3.14M56.07%1.94M
Shareholders'equity
Share capital 26.65%17.6K32.23%17.48K15.12%14.91K15.12%14.91K10.44%14.2K9.42%13.9K4.76%13.22K2.77%12.95K2.77%12.95K2.10%12.86K
-common stock 26.65%17.6K32.23%17.48K15.12%14.91K15.12%14.91K10.44%14.2K9.42%13.9K4.76%13.22K2.77%12.95K2.77%12.95K2.10%12.86K
Retained earnings -12.62%-63.56M-14.03%-61.85M-16.22%-60.21M-16.22%-60.21M-19.39%-58.39M-21.35%-56.44M-23.99%-54.24M-25.47%-51.8M-25.47%-51.8M-26.68%-48.91M
Paid-in capital 8.36%69.63M9.76%69.3M6.34%65.79M6.34%65.79M5.91%64.99M5.34%64.25M4.01%63.14M2.74%61.87M2.74%61.87M2.48%61.36M
Gains losses not affecting retained earnings 14.35%8.26K-86.69%4.23K-258.04%-14.13K-258.04%-14.13K-90.81%3.95K-58.65%7.22K949.01%31.79K382.97%8.94K382.97%8.94K935.15%42.99K
Total stockholders'equity -22.29%6.09M-16.41%7.48M-44.62%5.59M-44.62%5.59M-47.15%6.61M-46.02%7.84M-47.28%8.94M-46.73%10.09M-46.73%10.09M-41.21%12.51M
Total equity -22.29%6.09M-16.41%7.48M-44.62%5.59M-44.62%5.59M-47.15%6.61M-46.02%7.84M-47.28%8.94M-46.73%10.09M-46.73%10.09M-41.21%12.51M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data